Midterm Clinical and Angiographic Follow-Up for the First Food and Drug Administration-Approved Prospective, Single-Arm Trial of Primary Stenting for Stroke: SARIS (Stent-Assisted Recanalization for Acute Ischemic Stroke)

201162 citationsJournal Article

Authors

Elad I. Levy · University at Buffalo, State University of New York

Maryam Rahman · University of Florida

Alexander A. Khalessi · University at Buffalo, State University of New York

Patrick T. Beyer · University at Buffalo, State University of New York

Sabareesh K. Natarajan · University at Buffalo, State University of New York

Mary L. Hartney · University at Buffalo, State University of New York

Abstract

The midterm angiographic and clinical results following intracranial stent deployment for acute ischemic stroke are encouraging. Further study of primary stent-for-stroke treatment is warranted.

Topics & Keywords

Acute Ischemic Stroke Management Cerebrovascular and Carotid Artery Diseases Intracranial Aneurysms: Treatment and Complications

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurosurgery

Volume 69, Issue 4, pp. 915-920

DOI: 10.1227/neu.0b013e318222afd1

Field-Weighted Citation Impact: 5.48